benefits of using semaglutide GLP-1 for Weight Loss Benefits of Semaglutide GLP-1 Injections

[Article] [PubMed] [PMC]21

Semaglutide improves 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced motor impairments

Semaglutide is also FDA-approved to treat metabolic dysfunction-associated steatohepatitis (MASH), a condition that causes inflammation and scarring in the liver, including more serious scarring called advanced fibrosis

This neuroinflammation is a primary driver of the cognitive dysfunction, or "brain fog," seen in Long COVID

[DOI] [PMC free article] [PubMed] [Google Scholar] 74.Saito C, Lemasters JJ, Jaeschke H

This milestone positions Wegovy as the first GLP-1 receptor agonist approved for MASH, offering new hope to millions affected by this serious liver disease